Back to Search Start Over

Sequencing of the entire rpob gene and characterization of mutations in isolates of Mycobacterium tuberculosis circulating in an endemic tuberculosis setting.

Authors :
Luna JF
Montero H
Sampieri CL
Muñiz-Salazar R
Zenteno-Cuevas R
Source :
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2019 Dec; Vol. 19, pp. 98-103. Date of Electronic Publication: 2019 Mar 11.
Publication Year :
2019

Abstract

Objective: To evaluate the use of a sequencing procedure for the entire rpoB gene of Mycobacterium tuberculosis to identify mutations pre-rifampicin resistance determining region (RRDR), within RRDR, and post-RRDR in isolates circulating in a region affected by tuberculosis (TB).<br />Methods: Five primers were designed, with which five DNA fragments of rpoB were obtained, sequenced by Sanger, and analysed in silico in order to identify mutations over the entire rpoB gene in rifampicin-sensitive and rifampicin-resistant TB.<br />Results: It was possible to analyse the entire rpoB gene in five rifampicin-sensitive and 15 rifampicin-resistant isolates. Thirty-six mutations were identified. Two mutations were found pre-RRDR, nine within-RRDR and 25 post-RRDR. The most frequent mutations within RRDR were S531L (53%), followed by S512T (20%), all of which were found in rifampicin-resistant isolates. Of the 25 mutations found post-RRDR, 14 were only in resistant isolates, and the most frequent was D853N, which was present in 85% of isolates. Mutations E818K, D836N and T882P were observed in 80% of the rifampicin-resistant and rifampicin-sensitive isolates.<br />Conclusions: The proposed sequencing method allowed identification of mutations in the entire rpoB gene. This procedure represents a useful tool for diagnosing rifampicin resistance. The number of mutations that were found raises new questions about the diversity of mutations in the rpoB gene and their role in rifampicin resistance in regions where TB is endemic.<br /> (Copyright © 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
2213-7173
Volume :
19
Database :
MEDLINE
Journal :
Journal of global antimicrobial resistance
Publication Type :
Academic Journal
Accession number :
30872039
Full Text :
https://doi.org/10.1016/j.jgar.2019.03.001